93 related articles for article (PubMed ID: 10993742)
21. Regulation of mRNAs encoding MMP-9 and MMP-2, and their inhibitors TIMP-1 and TIMP-2 by androgens in the rat ventral prostate.
Limaye AM; Desai KV; Chavalmane AK; Kondaiah P
Mol Cell Endocrinol; 2008 Nov; 294(1-2):10-8. PubMed ID: 18675881
[TBL] [Abstract][Full Text] [Related]
22. [Type I and IV collagenases and their endogenous regulators in immortalized and transformed fibroblasts].
Solov'eva NI; Vinokurova SV; Dilakian EA; Gureeva TA; Zhurbitskaia VA; Balaevskaia TO
Vopr Med Khim; 2001; 47(1):72-9. PubMed ID: 11386000
[TBL] [Abstract][Full Text] [Related]
23. A matrix metalloproteinase inhibitor promotes granuloma formation during the early phase of Mycobacterium tuberculosis pulmonary infection.
Izzo AA; Izzo LS; Kasimos J; Majka S
Tuberculosis (Edinb); 2004; 84(6):387-96. PubMed ID: 15525562
[TBL] [Abstract][Full Text] [Related]
24. Matrix metalloproteinases MMP-2, -9 and tissue inhibitors TIMP-1, -2 expression and secretion by primary human osteoblast cells in response to titanium, zirconia, and alumina ceramics.
Oum'hamed Z; Garnotel R; Josset Y; Trenteseaux C; Laurent-Maquin D
J Biomed Mater Res A; 2004 Jan; 68(1):114-22. PubMed ID: 14661256
[TBL] [Abstract][Full Text] [Related]
25. [Effect of lipopolysaccharide on expression of matrix metalloproteinase-9 in human synoviocyte from patients with rheumatoid arthritis].
Liu BH; Li YT; Shen F; Zhao DY; Cheng GF
Yao Xue Xue Bao; 2003 Apr; 38(4):245-9. PubMed ID: 12889120
[TBL] [Abstract][Full Text] [Related]
26. Expression and activity of matrix metalloproteinase-2 in calcific aortic stenosis.
Kaden JJ; Vocke DC; Fischer CS; Grobholz R; Brueckmann M; Vahl CF; Hagl S; Haase KK; Dempfle CE; Borggrefe M
Z Kardiol; 2004 Feb; 93(2):124-30. PubMed ID: 14963678
[TBL] [Abstract][Full Text] [Related]
27. Matrix metalloproteinase 9 (MMP-9) is upregulated during scarless wound healing in athymic nude mice.
Manuel JA; Gawronska-Kozak B
Matrix Biol; 2006 Oct; 25(8):505-14. PubMed ID: 17010584
[TBL] [Abstract][Full Text] [Related]
28. Involvement of CD147 in overexpression of MMP-2 and MMP-9 and enhancement of invasive potential of PMA-differentiated THP-1.
Zhou J; Zhu P; Jiang JL; Zhang Q; Wu ZB; Yao XY; Tang H; Lu N; Yang Y; Chen ZN
BMC Cell Biol; 2005 May; 6(1):25. PubMed ID: 15904490
[TBL] [Abstract][Full Text] [Related]
29. Expression and response to angiotensin-converting enzyme inhibition of matrix metalloproteinases 2 and 9 in renal glomerular damage in young transgenic rats with renin-dependent hypertension.
Bolbrinker J; Markovic S; Wehland M; Melenhorst WB; van Goor H; Kreutz R
J Pharmacol Exp Ther; 2006 Jan; 316(1):8-16. PubMed ID: 16166267
[TBL] [Abstract][Full Text] [Related]
30. Differential expression of tissue inhibitor of metalloproteinases-3 in cultured astrocytes and neurons regulates the activation of matrix metalloproteinase-2.
Liu W; Furuichi T; Miyake M; Rosenberg GA; Liu KJ
J Neurosci Res; 2007 Mar; 85(4):829-36. PubMed ID: 17279554
[TBL] [Abstract][Full Text] [Related]
31. Opposite effects of high glucose on MMP-2 and TIMP-2 in human endothelial cells.
Ho FM; Liu SH; Lin WW; Liau CS
J Cell Biochem; 2007 May; 101(2):442-50. PubMed ID: 17203468
[TBL] [Abstract][Full Text] [Related]
32. Matrix metalloproteinase expression by endothelial cells in collagen lattices changes during co-culture with fibroblasts and upon induction of decorin expression.
Schönherr E; Schaefer L; O'Connell BC; Kresse H
J Cell Physiol; 2001 Apr; 187(1):37-47. PubMed ID: 11241347
[TBL] [Abstract][Full Text] [Related]
33. Induction of matrix metalloproteinases (MMPs) and tissue inhibitors of MMPs correlates with outcome of acute experimental pseudomonal keratitis.
Ikema K; Matsumoto K; Inomata Y; Komohara Y; Miyajima S; Takeya M; Tanihara H
Exp Eye Res; 2006 Dec; 83(6):1396-404. PubMed ID: 16968651
[TBL] [Abstract][Full Text] [Related]
34. Expression of matrix metalloproteinases and tissue inhibitors of metalloproteinase in uterine endometrial carcinoma and a correlation between expression of matrix metalloproteinase-7 and prognosis.
Misugi F; Sumi T; Okamoto E; Nobeyama H; Hattori K; Yoshida H; Matsumoto Y; Yasui T; Honda K; Ishiko O
Int J Mol Med; 2005 Oct; 16(4):541-6. PubMed ID: 16142384
[TBL] [Abstract][Full Text] [Related]
35. PAF-induced furin and MT1-MMP expression is independent of MMP-2 activation in corneal myofibroblasts.
Ottino P; He J; Axelrad TW; Bazan HE
Invest Ophthalmol Vis Sci; 2005 Feb; 46(2):487-96. PubMed ID: 15671273
[TBL] [Abstract][Full Text] [Related]
36. Expression of matrix metalloproteinases and their inhibitors in medulloblastomas and their prognostic relevance.
Ozen O; Krebs B; Hemmerlein B; Pekrun A; Kretzschmar H; Herms J
Clin Cancer Res; 2004 Jul; 10(14):4746-53. PubMed ID: 15269148
[TBL] [Abstract][Full Text] [Related]
37. Regulation of matrix metalloproteinases and tissue inhibitors of matrix metalloproteinases by Porphyromonas gingivalis in an engineered human oral mucosa model.
Andrian E; Mostefaoui Y; Rouabhia M; Grenier D
J Cell Physiol; 2007 Apr; 211(1):56-62. PubMed ID: 17226791
[TBL] [Abstract][Full Text] [Related]
38. Platelet-activating factor induces the gene expression of TIMP-1, -2, and PAI-1: imbalance between the gene expression of MMP-9 and TIMP-1 and -2.
Ottino P; Taheri F; Bazan HE
Exp Eye Res; 2002 Mar; 74(3):393-402. PubMed ID: 12014920
[TBL] [Abstract][Full Text] [Related]
39. Gelatinolytic and collagenolytic activity in periprosthetic tissues from loose hip endoprostheses.
Syggelos SA; Eleftheriou SC; Giannopoulou E; Panagiotopoulos E; Aletras AJ
J Rheumatol; 2001 Jun; 28(6):1319-29. PubMed ID: 11409126
[TBL] [Abstract][Full Text] [Related]
40. Comparison of matrix metalloproteinase expression between primary tumors with or without liver metastasis in pancreatic and colorectal carcinomas.
Matsuyama Y; Takao S; Aikou T
J Surg Oncol; 2002 Jun; 80(2):105-10. PubMed ID: 12173379
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
